4//SEC Filing
KIDRON NADAV 4
Accession 0001209191-22-043768
CIK 0001176309other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 8:00 PM ET
Size
8.3 KB
Accession
0001209191-22-043768
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-07-28+126,000→ 1,090,729 total - Award
Common Stock
2022-07-28+34,000→ 964,729 total - Tax Payment
Common Stock
2022-08-01$8.36/sh−12,631$105,595→ 1,078,098 total
Footnotes (3)
- [F1]Represents Common Stock granted by the Issuer that vested on August 1, 2022.
- [F2]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 42,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F3]Payment of tax liability by withholding securities related to the 34,000 shares of Common Stock granted on July 28, 2022.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001351779
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 8:00 PM ET
- Size
- 8.3 KB